Timothy D. Hunt
Chief Executive Officer chez Alliance for Regenerative Medicine
Profil
Timothy D.
Hunt is on the board of American Society of Gene & Cell Therapy and Chief Executive Officer for Alliance for Regenerative Medicine.
In the past Mr. Hunt was Senior Vice President-Corporate Affairs at Editas Medicine, Inc., Vice President-Public Affairs at Biogen, Inc., Senior Vice President-Public Affairs at Cubist Pharmaceuticals LLC, Chief Culture & Corporate Affairs Officer at Xilio Therapeutics, Inc., Director-State Government Affairs at BGR Holding LLC and Senior Manager-State Government Relations at GlaxoSmithKline LLC.
He received an undergraduate degree from Boston College and a graduate degree from Columbus School of Law.
Postes actifs de Timothy D. Hunt
Sociétés | Poste | Début |
---|---|---|
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Director/Board Member | - |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Chief Executive Officer | 06/09/2022 |
Anciens postes connus de Timothy D. Hunt
Sociétés | Poste | Fin |
---|---|---|
XILIO THERAPEUTICS, INC. | Human Resources Officer | 01/08/2022 |
EDITAS MEDICINE, INC. | Corporate Officer/Principal | 01/03/2020 |
BIOGEN INC. | Public Communications Contact | 01/01/2011 |
BGR Holding LLC
BGR Holding LLC Miscellaneous Commercial ServicesCommercial Services BGR Holding LLC provides legal services. It employs lawyers, policy specialists and other professionals to represents the interests of its clients at the federal level. BGR clients include international governments, trade associations, non-profits, academic institutions, hospitals, coalitions, state and local governments. The company was founded by Haley R. Barbourm, Lanny Griffith and Edward M. Rogers in 1991 and is headquartered in Washington, DC. | General Counsel | - |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | General Counsel | - |
Formation de Timothy D. Hunt
Boston College | Undergraduate Degree |
Columbus School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
BIOGEN INC. | Health Technology |
EDITAS MEDICINE, INC. | Health Technology |
XILIO THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
BGR Holding LLC
BGR Holding LLC Miscellaneous Commercial ServicesCommercial Services BGR Holding LLC provides legal services. It employs lawyers, policy specialists and other professionals to represents the interests of its clients at the federal level. BGR clients include international governments, trade associations, non-profits, academic institutions, hospitals, coalitions, state and local governments. The company was founded by Haley R. Barbourm, Lanny Griffith and Edward M. Rogers in 1991 and is headquartered in Washington, DC. | Commercial Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Commercial Services |